The usual cause for the fund is to invest in rounds with 6 partakers. Despite the Wilmont Ventures, startups are often financed by Valar Ventures, Mark Evans, Kindred Capital. The meaningful sponsors for the fund in investment in the same round are Valar Ventures, SciFi VC, Kindred Capital.
The fund is generally included in less than 2 deals every year. The important activity for fund was in 2017. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The fund has exact preference in some founders of portfolio startups. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight System1 Biosciences, Kalo. Among the most popular fund investment industries, there are Freelance, Information Services.
Related Funds
Fund Name | Location |
Balanced | California, San Francisco, United States |
Bethesda Softworks | Maryland, Rockville, United States |
Come Up Capital | Minneapolis, Minnesota, United States |
eGarden Ventures | China, Hong Kong, Hong Kong Island |
Inversiones Oranda | - |
OLX Group | Amsterdam, Noord-Holland, The Netherlands |
Rannapo Partners | New York, New York, United States |
Smart Capital (China) Ltd | China, Guangdong, Shenzhen |
Spar Nord Bank A/S | Aalborg, Denmark, North Denmark Region |
Yilian Shixun | Beijing, Beijing, China |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
System1 Biosciences | $25M | 12 Sep 2018 | San Francisco, California, United States | ||
Kalo | $13M | 23 Mar 2017 | New York, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
System1 Biosciences | $25M | 12 Sep 2018 | San Francisco, California, United States | ||
Kalo | $13M | 23 Mar 2017 | New York, United States |